Retention rate of TNF inhibitors versus IL-17 inhibitors in ankylosing spondylitis patients with prior biologics experience
In patients with AS who had prior experience with biologics, the drug retention of TNF inhibitors tended to be higher compared to IL-17 inhibitors in real-world clinical practice. However, the factors significantly associated with higher drug survival were a lower number of previously exposed biologics and a lower BASDAI.
Authors
- Bong-Woo Lee (ORCID: https://orcid.org/0000-0001-5894-9305)
- Wan‐Uk Kim (ORCID: https://orcid.org/0000-0001-8224-8496)
- Ji Hyeon Ju (ORCID: https://orcid.org/0009-0001-7649-5076)
- Seung‐Ki Kwok (ORCID: https://orcid.org/0000-0002-6142-8364)
- Jennifer Jooha Lee (ORCID: https://orcid.org/0000-0001-6873-6629)
- Youngjae Park (ORCID: https://orcid.org/0000-0001-8530-713X)
- Ji Won Yang (ORCID: https://orcid.org/0000-0001-7629-6395)
- Sung‐Hwan Park (ORCID: https://orcid.org/0009-0001-1899-538X)
Institutions
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- Arthritis Research & Therapy
- Published
- 2025-07-04
- DOI
- https://doi.org/10.1186/s13075-025-03601-z
- Citations
- 2
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.34
Funders
- National Research Foundation
- Catholic University of Korea
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea
- Seoul St. Mary's Hospital, Catholic University of Korea